417 related articles for article (PubMed ID: 27558522)
1. Preparation and evaluation of niosome gel containing acyclovir for enhanced dermal deposition.
Jacob S; Nair AB; Al-Dhubiab BE
J Liposome Res; 2017 Dec; 27(4):283-292. PubMed ID: 27558522
[TBL] [Abstract][Full Text] [Related]
2. Enhanced transdermal delivery of acyclovir sodium via elastic liposomes.
Jain SK; Gupta Y; Jain A; Rai K
Drug Deliv; 2008; 15(3):141-7. PubMed ID: 18379926
[TBL] [Abstract][Full Text] [Related]
3. Formulation and evaluation of proniosomes containing lornoxicam.
Madan JR; Ghuge NP; Dua K
Drug Deliv Transl Res; 2016 Oct; 6(5):511-8. PubMed ID: 27255375
[TBL] [Abstract][Full Text] [Related]
4. Topical delivery of acyclovir and ketoconazole.
Jacobs GA; Gerber M; Malan MM; du Preez JL; Fox LT; du Plessis J
Drug Deliv; 2016; 23(2):631-41. PubMed ID: 25005585
[TBL] [Abstract][Full Text] [Related]
5. Different BRIJ97 colloid systems as potential enhancers of acyclovir skin permeation and depot.
Mazzotta E; Oliviero Rossi C; Muzzalupo R
Colloids Surf B Biointerfaces; 2019 Jan; 173():623-631. PubMed ID: 30368209
[TBL] [Abstract][Full Text] [Related]
6. Nano-proniosomes enhancing the transdermal delivery of mefenamic acid.
Wen MM; Farid RM; Kassem AA
J Liposome Res; 2014 Dec; 24(4):280-9. PubMed ID: 24779560
[TBL] [Abstract][Full Text] [Related]
7. Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: In-vitro characterization and in-vivo activity.
Qumbar M; Ameeduzzafar ; Imam SS; Ali J; Ahmad J; Ali A
Biomed Pharmacother; 2017 Sep; 93():255-266. PubMed ID: 28738502
[TBL] [Abstract][Full Text] [Related]
8. Transdermal drug delivery of paroxetine through lipid-vesicular formulation to augment its bioavailability.
El-Nabarawi MA; Bendas ER; El Rehem RT; Abary MY
Int J Pharm; 2013 Feb; 443(1-2):307-17. PubMed ID: 23337629
[TBL] [Abstract][Full Text] [Related]
9. Sustained release of acyclovir from nano-liposomes and nano-niosomes: an in vitro study.
Mukherjee B; Patra B; Layek B; Mukherjee A
Int J Nanomedicine; 2007; 2(2):213-25. PubMed ID: 17722549
[TBL] [Abstract][Full Text] [Related]
10. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability.
Padamwar MN; Pokharkar VB
Int J Pharm; 2006 Aug; 320(1-2):37-44. PubMed ID: 16707237
[TBL] [Abstract][Full Text] [Related]
11. Enhanced dermal delivery of diflucortolone valerate using lecithin/chitosan nanoparticles: in-vitro and in-vivo evaluations.
Özcan I; Azizoğlu E; Senyiğit T; Özyazıcı M; Özer Ö
Int J Nanomedicine; 2013; 8():461-75. PubMed ID: 23390364
[TBL] [Abstract][Full Text] [Related]
12. Preparation and evaluation of optimized zolmitriptan niosomal emulgel.
Mohamed MI; Abdelbary AA; Kandil SM; Mahmoud TM
Drug Dev Ind Pharm; 2019 Jul; 45(7):1157-1167. PubMed ID: 30919700
[No Abstract] [Full Text] [Related]
13. Ascorbic acid derivative-loaded modified aspasomes: formulation,
Aboul-Einien MH; Kandil SM; Abdou EM; Diab HM; Zaki MSE
J Liposome Res; 2020 Mar; 30(1):54-67. PubMed ID: 30821553
[TBL] [Abstract][Full Text] [Related]
14. Hydroxychloroquine niosomes: a new trend in topical management of oral lichen planus.
Bendas ER; Abdullah H; El-Komy MH; Kassem MA
Int J Pharm; 2013 Dec; 458(2):287-95. PubMed ID: 24184035
[TBL] [Abstract][Full Text] [Related]
15. Influence of a niosomal formulation on the oral bioavailability of acyclovir in rabbits.
Attia IA; El-Gizawy SA; Fouda MA; Donia AM
AAPS PharmSciTech; 2007 Dec; 8(4):E106. PubMed ID: 18181527
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo evaluation of Bola-surfactant containing niosomes for transdermal delivery.
Paolino D; Muzzalupo R; Ricciardi A; Celia C; Picci N; Fresta M
Biomed Microdevices; 2007 Aug; 9(4):421-33. PubMed ID: 17252206
[TBL] [Abstract][Full Text] [Related]
17. Magnesium ascorbyl phosphate vesicular carriers for topical delivery; preparation, in-vitro and ex-vivo evaluation, factorial optimization and clinical assessment in melasma patients.
Kandil SM; Soliman II; Diab HM; Bedair NI; Mahrous MH; Abdou EM
Drug Deliv; 2022 Dec; 29(1):534-547. PubMed ID: 35156490
[TBL] [Abstract][Full Text] [Related]
18. Nanodesign of olein vesicles for the topical delivery of the antioxidant resveratrol.
Pando D; Caddeo C; Manconi M; Fadda AM; Pazos C
J Pharm Pharmacol; 2013 Aug; 65(8):1158-67. PubMed ID: 23837583
[TBL] [Abstract][Full Text] [Related]
19. Delivery of oat-derived phytoceramides into the stratum corneum of the skin using nanocarriers: Formulation, characterization and in vitro and ex-vivo penetration studies.
Tessema EN; Gebre-Mariam T; Paulos G; Wohlrab J; Neubert RHH
Eur J Pharm Biopharm; 2018 Jun; 127():260-269. PubMed ID: 29501672
[TBL] [Abstract][Full Text] [Related]
20. Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study.
Abdelbary AA; AbouGhaly MH
Int J Pharm; 2015 May; 485(1-2):235-43. PubMed ID: 25773359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
